CY2009001I1 - Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης - Google Patents

Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης

Info

Publication number
CY2009001I1
CY2009001I1 CY200900001C CY2009001C CY2009001I1 CY 2009001 I1 CY2009001 I1 CY 2009001I1 CY 200900001 C CY200900001 C CY 200900001C CY 2009001 C CY2009001 C CY 2009001C CY 2009001 I1 CY2009001 I1 CY 2009001I1
Authority
CY
Cyprus
Prior art keywords
crystal form
new crystal
pyrrolidylthiocarbapenem derivative
pyrrolidylthiocarbapenem
derivative
Prior art date
Application number
CY200900001C
Other languages
English (en)
Other versions
CY2009001I2 (el
Original Assignee
Shionogi & Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18614158&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2009001(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co., Ltd filed Critical Shionogi & Co., Ltd
Publication of CY2009001I2 publication Critical patent/CY2009001I2/el
Publication of CY2009001I1 publication Critical patent/CY2009001I1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CY200900001C 2000-03-31 2009-01-23 Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης CY2009001I1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000099868 2000-03-31
PCT/JP2001/002834 WO2001072750A1 (fr) 2000-03-31 2001-03-30 Nouvelle forme cristalline d'un derive de pyrrolidylthiocarbapenem

Publications (2)

Publication Number Publication Date
CY2009001I2 CY2009001I2 (el) 2009-11-04
CY2009001I1 true CY2009001I1 (el) 2009-11-04

Family

ID=18614158

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20051101453T CY1105674T1 (el) 2000-03-31 2005-11-28 Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
CY200900001C CY2009001I1 (el) 2000-03-31 2009-01-23 Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20051101453T CY1105674T1 (el) 2000-03-31 2005-11-28 Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης

Country Status (17)

Country Link
US (5) US20030153191A1 (el)
EP (1) EP1270575B1 (el)
JP (1) JP3375084B2 (el)
KR (1) KR100472842B1 (el)
CN (1) CN1192030C (el)
AT (1) ATE304014T1 (el)
AU (2) AU4469201A (el)
BR (1) BRPI0109712B8 (el)
CA (1) CA2404703C (el)
CY (2) CY1105674T1 (el)
DE (1) DE60113243T2 (el)
DK (1) DK1270575T3 (el)
ES (1) ES2252205T3 (el)
MX (1) MXPA02009592A (el)
TW (1) TWI293631B (el)
WO (1) WO2001072750A1 (el)
ZA (1) ZA200207675B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3375084B2 (ja) * 2000-03-31 2003-02-10 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の新型結晶
JP5004355B2 (ja) * 2001-05-10 2012-08-22 塩野義製薬株式会社 アセチルチオピロリジン誘導体の製法
WO2003042215A1 (en) * 2001-11-16 2003-05-22 Ranbaxy Laboratories Limited Process for the preparation of crystalline imipenem
TWI353855B (en) 2005-05-26 2011-12-11 Shionogi & Co Method for preparing an aqueous solution of doripe
JP5671204B2 (ja) * 2006-04-28 2015-02-18 株式会社カネカ カルバペネム抗生物質中間体の改良された晶析方法
CN101466713A (zh) * 2006-07-03 2009-06-24 成都地奥九泓制药厂 多尼培南的新结晶及其制备方法和用途
CN101191787B (zh) * 2006-11-21 2011-07-27 上海医药工业研究院 高效液相色谱法测定多利培南含量的方法
EP2276762B1 (en) 2008-03-24 2014-10-01 Ranbaxy Laboratories Limited Process for the preparation of sterile doripenem
CN103025733B (zh) * 2010-06-03 2015-11-25 山东轩竹医药科技有限公司 碳青霉烯类衍生物或其水合物的晶型及其制备方法与用途
CN102977101A (zh) * 2011-09-07 2013-03-20 中国人民解放军军事医学科学院毒物药物研究所 多尼培南一水合物、其药物组合物、其制备方法和用途
CN102285988B (zh) * 2011-09-08 2012-09-05 上海希迈医药科技有限公司 一种多尼培南水合物晶体及其制备方法
WO2013068910A1 (en) * 2011-11-08 2013-05-16 Ranbaxy Laboratories Limited Process for the preparation of polymorphs of doripenem
CN104072497B (zh) * 2013-03-29 2017-10-03 石药集团中奇制药技术（石家庄）有限公司 一种多尼培南新结晶及其制备方法
CN103389347B (zh) * 2013-07-26 2015-12-09 深圳市海滨制药有限公司 高效液相色谱法测定多尼培南的方法
CN106255694A (zh) * 2014-04-28 2016-12-21 Jw制药公司 新型多尼培南晶体及其制备方法
KR20160007679A (ko) 2016-01-04 2016-01-20 제일약품주식회사 도리페넴의 신규한 결정형

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
US5539102A (en) * 1992-02-21 1996-07-23 Shionogi Seiyaku Kabushiki Kaisha Production method for sulfamide
DE69528166T2 (de) * 1994-05-02 2003-04-30 Shionogi & Co Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
JP3558684B2 (ja) * 1994-06-28 2004-08-25 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の乾燥方法
JP3375084B2 (ja) * 2000-03-31 2003-02-10 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の新型結晶
AU2004212402B2 (en) * 2003-02-14 2009-11-26 Shionogi & Co., Ltd. Crystal of intermediate for carbapenem
EP2401278A4 (en) 2009-02-26 2012-07-04 Orchid Chemicals & Pharm Ltd IMPROVED PROCESS FOR THE PREPARATION OF A CARBAPENEM ANTIBIOTICS

Also Published As

Publication number Publication date
CN1192030C (zh) 2005-03-09
DK1270575T3 (da) 2006-01-16
CA2404703A1 (en) 2002-09-26
US8247402B2 (en) 2012-08-21
MXPA02009592A (es) 2003-03-12
EP1270575B1 (en) 2005-09-07
BRPI0109712B8 (pt) 2021-05-25
US20070060562A1 (en) 2007-03-15
US9221823B2 (en) 2015-12-29
EP1270575A4 (en) 2004-02-18
TWI293631B (el) 2008-02-21
ATE304014T1 (de) 2005-09-15
US20030153191A1 (en) 2003-08-14
DE60113243D1 (de) 2005-10-13
US20130059831A1 (en) 2013-03-07
AU2001244692B2 (en) 2004-10-14
EP1270575A1 (en) 2003-01-02
US20080207586A1 (en) 2008-08-28
US20150031664A1 (en) 2015-01-29
BRPI0109712B1 (pt) 2017-10-24
CN1432016A (zh) 2003-07-23
ES2252205T3 (es) 2006-05-16
BR0109712A (pt) 2003-04-29
KR20020087446A (ko) 2002-11-22
JP3375084B2 (ja) 2003-02-10
AU4469201A (en) 2001-10-08
CY2009001I2 (el) 2009-11-04
KR100472842B1 (ko) 2005-03-10
ZA200207675B (en) 2003-09-25
DE60113243T2 (de) 2006-02-16
CA2404703C (en) 2007-06-05
CY1105674T1 (el) 2010-07-28
WO2001072750A1 (fr) 2001-10-04

Similar Documents

Publication Publication Date Title
CY2009001I2 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
AR028567A1 (es) Nuevos derivados de fenil-propargileter
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
IS6492A (is) Ný bíarýlkarboxamíð
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
AR028596A1 (es) Nuevos derivados de fenilglicina
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
ATE298332T1 (de) Decahydro-isochinolinderivate
ATE297920T1 (de) Linezolid-krystall form ii
DK1280809T3 (da) Antitumorecteinascidinderivater
DE60125415D1 (de) Formeinsatz
EE05020B1 (et) Glburiidi ravimkoostis
ATE414056T1 (de) Substituierte c-cyclohexylmethylamin-derivative
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
DK1322592T4 (da) Substituerede 1-aminobutan-3-ol-derivater
DK1246791T3 (da) Aminomethyl-phenyl-cyklohexanonderivater
ATE361274T1 (de) Substituierte 5-amino-1-penten-3-ol-derivate
ATE374776T1 (de) Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no) 2-fenylpyran-4-on-derivater
UA4579S (uk) Дозиметр-радіометр гамма-бета-випромінювань
FIU20000034U0 (fi) Kanteleen sävelvaihtomekanismi
DK1246793T3 (da) Substituerede aminomethyl-phenyl-cyclohexanderivater
SE0004348D0 (sv) Nytt förfarande
CA91052S (fr) Montre-bracelet
DK1274710T3 (da) Hidtil ukendte heteroaryl-diazabicycloalkaner